Boston Scientific Announces Schedule for EuroPcr 2007 ( t; position: relative;> Boston Scien...)

Boston Scientific Announces Schedule for EuroPcr 2007

t; position: relative;">

Boston Scientific will present its latest innovations at booth D08 in the Exhibit Hall, including its drug-eluting stent program and peripheral treatment options. Additionally, the Company will introduce a software update for the iLab(TM) Ultrasound Imaging System, which further enhances compatibility and connectivity of iLab's IVUS images with Picture and Communication Systems (PACS) at cardiac catheterization labs.

PROMUS, TAXUS, Express and Express2 are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of Abbott. The SPIRIT Clinical Program is sponsored by Abbott. The PROMUS Stent is not approved for sale in the U.S.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, integration of acquired companies, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.


    CONTACT:  Paul Donovan

              508-650-8541 (office)

              508-667-5165 (mobile)

              Media Relations

              Boston Scientific Corporation


              Dan Brennan

              508-650-8538 (office)

              617-459-2703 (mobile)

              Investor Relations

              Boston Scientific Corporation

Boston
'"/>

Page: 1 2 3 4 5
Related medicine technology :

1. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
4. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
6. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
7. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
8. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
9. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
10. Inspire Announces Presentations at Two European Scientific Conferences
11. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting

Post Your Comments:

(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit

(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,

(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S

Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2 Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3 Amber Pharmacy Earns Accreditation From ACHC 2 Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2 Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1 Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2 Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 1 Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 2 Researcher honored for experimental work in nanotechnology 14533 1 Researcher honored for experimental work in nanotechnology 14533 2

[0] Vermillion Files Amended Plan of Reorganization and Exchanges Debt [0] Amber Pharmacy Earns Accreditation From ACHC [0] Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland

... April 11, 2007 (PRIME NEWSWIRE) --,Hana Bioscienc...sed,on advancing cancer care, will present preclin...ion at the American Association,for Cancer Researc...geles, California. , Abstract No. 2210: "Combining...mall cell lung cancer (NSCLC) athymic nude,mice xe...

...onex Inc. (TSX:LPX), a,biopharmaceutical company s...d to High Density Lipoprotein (HDL), often called,...om further,analysis of the Phase I/II Clinical Tri...ped for the treatment of dyslipidemia and,heart di...indicated that all,blood chemistry and blood press...

Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2 Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3 Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2 Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3

Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for

(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W

(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment

...procedures are generally being fleased from patien...ne of California, observed a study at present whic...sary fertility procedures.// Lawrence Werlin,...gnosis (PGD) for three distinct groups of women. P...

...n pointed at reducing carbon monoxide emissions ha...onoxide can be fatal if inhaled and is involved in...ear. //The main sources of carbon monoxide are veh...talytic converters in cars helps bring down the ca...

...to researchers, it may be possible to increase the...shortage of organs for transplantation.// Research...ng at the supply of lungs for transplant. They not...hecked 30 pairs of lungs that had been rejected fo...

...to researchers in England, a baby's birth weight i...late adulthood. The study also shows women with th...risk of developing diabetes.// More than 4,10...ing among those with the highest insulin resistanc...

...rs at the Colulmbia University found that eating m...eloping Alzheimer's disease in some people. Previo...ricted diet tend to live longer. //Researchers fee...lso damage cells and may increase the damage done ...

...antioxidants have always been beneficial to our bo...tent is released from the grain, and thereby makin...e has always been a common misconception that boil...ou may well gain more antioxidant power than you l...

Other Medicine News:Health News:Diet combined to Alzheimer's disease 2

Benefits in fertility procedures Carbon monoxide passes down Time to re-assess lung donation concept Link between birth weight and Insulin Resistance Diet combined to Alzheimer's disease Sweet corn releases antioxidants on cooking

... Clear Plus™ Uncuffed Endotracheal Tube w. F...et inside. Sterile, Single use. A quality Rusch en... is ready to use saving you time and storage space...ate smooth withdrawal. It is designed with a soft ...

Slick Set® Uncuffed

Cuffed Nasoral Magill

...ubber tube with Murphy eye. Laser resistant foam s...uffs (One inside other) 40cm (16") long, Single Us...access and optimum visibility within the operating...he tube shaft has a special laser-guard of approx....

Medicine Products:

Uncuffed Nasoral Murphy With Stylet Slick Set® Uncuffed Cuffed Nasoral Magill Cuffed Oral Murphy Laser-Resistant

( t; position: relative;> Boston Scien...)Boston Scientific Announces Schedule for EuroPcr 2007,Health